These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27774980)

  • 21. Protein-protein interactions as drug targets.
    Skwarczynska M; Ottmann C
    Future Med Chem; 2015; 7(16):2195-219. PubMed ID: 26510391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of chemical libraries with potentially bioactive molecules applying a maximum common substructure concept.
    Lisurek M; Rupp B; Wichard J; Neuenschwander M; von Kries JP; Frank R; Rademann J; Kühne R
    Mol Divers; 2010 May; 14(2):401-8. PubMed ID: 19685275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving small molecule virtual screening strategies for the next generation of therapeutics.
    Wingert BM; Camacho CJ
    Curr Opin Chem Biol; 2018 Jun; 44():87-92. PubMed ID: 29920436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of a polyheterocyclic benzopyran library with diverse core skeletons through diversity-oriented synthesis pathway.
    Oh S; Jang HJ; Ko SK; Ko Y; Park SB
    J Comb Chem; 2010 Jul; 12(4):548-58. PubMed ID: 20515049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent achievements and current trajectories of diversity-oriented synthesis.
    Gerry CJ; Schreiber SL
    Curr Opin Chem Biol; 2020 Jun; 56():1-9. PubMed ID: 31622927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple Chemical Features Impact Biological Performance Diversity of a Highly Active Natural Product-Inspired Library.
    Hippman RS; Pavlinov I; Gao Q; Mavlyanova MK; Gerlach EM; Aldrich LN
    Chembiochem; 2020 Nov; 21(21):3137-3145. PubMed ID: 32558167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in multicomponent reactions for diversity-oriented synthesis.
    Biggs-Houck JE; Younai A; Shaw JT
    Curr Opin Chem Biol; 2010 Jun; 14(3):371-82. PubMed ID: 20392661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of a sparse matrix design strategy to the synthesis of dos libraries.
    Akella LB; Marcaurelle LA
    ACS Comb Sci; 2011 Jul; 13(4):357-64. PubMed ID: 21526822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of polyheterocyclic benzopyran library with diverse core skeletons through diversity-oriented synthesis pathway: part II.
    Zhu M; Lim BJ; Koh M; Park SB
    ACS Comb Sci; 2012 Feb; 14(2):124-34. PubMed ID: 22181986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signaling.
    Wang X; Fonseca BD; Tang H; Liu R; Elia A; Clemens MJ; Bommer UA; Proud CG
    J Biol Chem; 2008 Nov; 283(45):30482-92. PubMed ID: 18676370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A design strategy for drug-like polyheterocycles with privileged substructures for discovery of specific small-molecule modulators.
    Oh S; Park SB
    Chem Commun (Camb); 2011 Dec; 47(48):12754-61. PubMed ID: 21869959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Toll-like receptor signaling inhibitors based on selective activation of hierarchically acting signaling proteins.
    Ippagunta SK; Pollock JA; Sharma N; Lin W; Chen T; Tawaratsumida K; High AA; Min J; Chen Y; Guy RK; Redecke V; Katzenellenbogen JA; Häcker H
    Sci Signal; 2018 Aug; 11(543):. PubMed ID: 30108181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular basis of the multifaceted functions of human leucyl-tRNA synthetase in protein synthesis and beyond.
    Liu RJ; Long T; Li H; Zhao J; Li J; Wang M; Palencia A; Lin J; Cusack S; Wang ED
    Nucleic Acids Res; 2020 May; 48(9):4946-4959. PubMed ID: 32232361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of an Irreversible and Cell-Active BCL6 Inhibitor Selectively Targeting Cys53 Located at the Protein-Protein Interaction Interface.
    Sameshima T; Yamamoto T; Sano O; Sogabe S; Igaki S; Sakamoto K; Ida K; Gotou M; Imaeda Y; Sakamoto J; Miyahisa I
    Biochemistry; 2018 Feb; 57(8):1369-1379. PubMed ID: 29293322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic Diversity-Oriented Synthesis of Reduced Flavones from γ-Pyrones to Probe Biological Performance Diversity.
    Gerlach EM; Korkmaz MA; Pavlinov I; Gao Q; Aldrich LN
    ACS Chem Biol; 2019 Jul; 14(7):1536-1545. PubMed ID: 31184855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of the first chemical tools to regulate MKK3-mediated MYC activation in cancer.
    Yang X; Fan D; Troha AH; Ahn HM; Qian K; Liang B; Du Y; Fu H; Ivanov AA
    Bioorg Med Chem; 2021 Sep; 45():116324. PubMed ID: 34333394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hot spot-based design of small-molecule inhibitors for protein-protein interactions.
    Guo W; Wisniewski JA; Ji H
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2546-54. PubMed ID: 24751445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancements to the Rosetta Energy Function Enable Improved Identification of Small Molecules that Inhibit Protein-Protein Interactions.
    Bazzoli A; Kelow SP; Karanicolas J
    PLoS One; 2015; 10(10):e0140359. PubMed ID: 26484863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyrimidine Triazole Thioether Derivatives as Toll-Like Receptor 5 (TLR5)/Flagellin Complex Inhibitors.
    Yan L; Liang J; Yao C; Wu P; Zeng X; Cheng K; Yin H
    ChemMedChem; 2016 Apr; 11(8):822-6. PubMed ID: 26634412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of lead compounds as antagonists of protein Bcl-xL with a diversity-oriented multidisciplinary approach.
    Di Micco S; Vitale R; Pellecchia M; Rega MF; Riva R; Basso A; Bifulco G
    J Med Chem; 2009 Dec; 52(23):7856-67. PubMed ID: 19852471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.